参考文献/References:
[1] Englund D A,Zhang X,Aversa Z,et al. Skeletal muscle aging,cellular senescence,and senotherapeutics: current knowledge and future directions[J].Mech Ageing Dev,2021,200:111595.DOI:10.1016/j.mad.2021.111595.
[2] Cypess AM.Reassessing human adipose tissue[J].N Engl J Med,2022,386(8):768-779.DOI:10.1056/NEJMra2032804.
[3] Palmer AK,Xu M,Zhu Y,et al.Targeting senescent cells alleviates obesity-induced metabolic dysfunction[J].Aging Cell,2019,18(3):e12950.DOI:10.1111/acel.12950.
[4] Di Micco R,Krizhanovsky V,Baker D,et al.Cellular senescence in ageing:from mechanisms to therapeutic opportunities[J].Nat Rev Mol Cell Biol,2021,22(2):75-95.DOI:10.1038/s41580-020-00314-w.
[5] Ou MY,Zhang H,Tan PC,et al.Adipose tissue aging:mechanisms and therapeutic implications[J].Cell Death Dis,2022,13(4):300.DOI:10.1038/s41419-022-04752-6.
[6] Stout MB,Justice JN,Nicklas BJ,et al.Physiological aging:links among adipose tissue dysfunction,diabetes,and frailty[J].Physiology(Bethesda),2017,32(1):9-19.DOI:10.1152/physiol.00012.2016.
[7] Lee G,Kim YY,Jang H,et al.SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity[J].Cell Metab,2022,34(5):702-718.DOI:10.1016/j.cmet.2022.03.010.
[8] Frasca D,Blomberg BB.Adipose tissue,immune aging,and cellular senescence[J].Semin Immunopathol,2020,42(5):573-587.DOI:10.1007/s00281-020-00812-1.
[9] Smith U,Li Q,Ryden M,et al.Cellular senescence and its role in white adipose tissue[J].Int J Obes(Lond),2021,45(5):934-943.DOI:10.1038/s41366-021-00757-x.
[10] Liu Z,Wu KKL,Jiang X,et al.The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders[J].Clin Sci(Lond),2020,134(2):315-330.DOI:10.1042/CS20190966.
[11] Vergoni B,Cornejo PJ,Gilleron J,et al.DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes[J].Diabetes,2016,65(10):3062-3074.DOI:10.2337/db16-0014.
[12] Fu W,Liu Y,Sun C,et al.Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy[J].FASEB J,2019,33(1):844-856.DOI:10.1096/fj.201800577R.
[13] Liu Z,Jin L,Yang JK,et al.The dysfunctional MDM2-p53 axis in adipocytes contributes to aging-related metabolic complications by induction of lipodystrophy[J].Diabetes,2018,67(11):2397-2409.DOI:10.2337/db18-0684.
[14] Camell CD,Sander J,Spadaro O,et al.Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing[J].Nature,2017,550(7674):119-123.DOI:10.1038/nature24022.
[15] Lee YH,Kim SR,Han DH,et al.Senescent T cells predict the development of hyperglycemia in humans[J].Diabetes,2019,68(1):156-162.DOI:10.2337/db17-1218.
[16] Gustafson B,Nerstedt A,Smith U.Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells[J].Nat Commun,2019,10(1):2757.DOI:10.1038/s41467-019-10688-x.
[17] da Silva PFL,Ogrodnik M,Kucheryavenko O,et al.The bystander effect contributes to the accumulation of senescent cells in vivo[J].Aging Cell,2019,18(1):e12848.DOI:10.1111/acel.12848.
[18] Yang LW,Song M,Li YL,et al.L-Carnitine inhibits the senescence-associated secretory phenotype of aging adipose tissue by JNK/p53 pathway[J].Biogerontology,2019,20(2):203-211.DOI:10.1007/s10522-018-9787-z.
[19] Ehrhardt N,Cui J,Dagdeviren S,et al.Adiposity-independent effects of aging on insulin sensitivity and clearance in mice and humans[J].Obesity(Silver Spring),2019,27(3):434-443.DOI:10.1002/oby.22418.
[20] Wang M,Tan Y,Shi Y,et al.Diabetes and sarcopenic obesity:pathogenesis,diagnosis,and treatments[J].Front Endocrinol(Lausanne),2020,11:568.DOI:10.3389/fendo.2020.00568.
[21] Yi HS,Kim SY,Kim JT,et al.T-cell senescence contributes to abnormal glucose homeostasis in humans and mice[J].Cell Death Dis,2019,10(3):249.DOI:10.1038/s41419-019-1494-4.
[22] Xu M,Pirtskhalava T,Farr JN,et al.Senolytics improve physical function and increase lifespan in old age[J].Nat Med,2018,24(8):1246-1256.DOI:10.1038/s41591-018-0092-9.
[23] De Cecco M,Ito T,Petrashen AP,et al.L1 drives IFN in senescent cells and promotes age-associated inflammation[J].Nature,2019,566(7742):73-78.DOI:10.1038/s41586-018-0784-9.
[24] Li Q,Hagberg CE,Silva Cascales H,et al.Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce[J].Nat Med,2021,27(11):1941-1953.DOI:10.1038/s41591-021-01501-8.
[25] Zhang R,Yao K,Chen S,et al.Liraglutide promotes angiogenesis in adipose tissue via suppression of adipocyte-derived IL-6[J].Biochem Biophys Res Commun,2023,651:8-19.DOI:10.1016/j.bbrc.2023.02.007.
相似文献/References:
[1]刘美娟,朱惠娟,龚凤英.Glypican-,4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity,insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(06):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
[2]李耀辉,侯沃霖,刘芳.肥胖与脂肪组织慢性炎性反应[J].国际内分泌代谢杂志,2016,36(05):342.[doi:10.3760/cma.j.issn.1673-4157.2016.05.15]
Li Yaohui,Hou Wolin,Liu Fang.Obesity and chronic inflammation in adipose tissue[J].International Journal of Endocrinology and Metabolism,2016,36(06):342.[doi:10.3760/cma.j.issn.1673-4157.2016.05.15]
[3]张娴 陈宏.新型脂肪因子与肥胖相关代谢性疾病[J].国际内分泌代谢杂志,2018,38(03):171.[doi:10.3760/cma.j.issn.1673-4157.2018.03.007]
Zhang Xian,Chen Hong.Novel adipokines and obesity-related metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(06):171.[doi:10.3760/cma.j.issn.1673-4157.2018.03.007]